Novavax Shares Gain Over 29% After $350 Million Vaccine Deal With Canada

Shares of Novavax soared over 29% after the Canadian government agreed to pay the biotech firm almost $350 million for canceling delivery of some COVID-19 vaccines previously ordered.

admin